Athina Giannoudis

Athina Giannoudis

University of Liverpool

H-index: 25

Europe-United Kingdom

About Athina Giannoudis

Athina Giannoudis, With an exceptional h-index of 25 and a recent h-index of 16 (since 2020), a distinguished researcher at University of Liverpool, specializes in the field of Breast Cancer, Pharmacogenetics, Drug transporters, Molecular biology, CML.

His recent articles reflect a diverse array of research interests and contributions to the field:

Targetable genomic profiling of breast cancer brain metastases identifies alterations and genomic signatures relevant to immune-checkpoint and PARP inhibitors

A Bioinformatic Characterisation of the Glyolytic Enzyme ENO1 as a Biomarker of Breast Cancer Progression

Abstract P5-14-10: Targetable alterations and genomic signatures within breast cancer brain metastases: Data from comprehensive genomic profiling of 761 breast cancer brain …

Identification of targetable genomic profiling of breast cancer brain metastases identifies alterations and genomic signatures relevant to immune-checkpoint and PARP inhibitors

ENO1 as a biomarker of breast cancer progression and metastasis–a bioinformatic approach

Characterisation of the immune microenvironment of primary breast cancer and brain metastasis reveals depleted T-cell response associated to ARG2 expression

The role of CPT1A as a biomarker of breast cancer progression: a bioinformatic approach

20P The importance of ARG2 expression in the immune-depleted microenvironment of primary breast cancer and brain metastasis

Athina Giannoudis Information

University

Position

Dr

Citations(all)

4233

Citations(since 2020)

1072

Cited By

3514

hIndex(all)

25

hIndex(since 2020)

16

i10Index(all)

38

i10Index(since 2020)

22

Email

University Profile Page

Google Scholar

Athina Giannoudis Skills & Research Interests

Breast Cancer

Pharmacogenetics

Drug transporters

Molecular biology

CML

Top articles of Athina Giannoudis

Targetable genomic profiling of breast cancer brain metastases identifies alterations and genomic signatures relevant to immune-checkpoint and PARP inhibitors

2024/4/26

Athina Giannoudis
Athina Giannoudis

H-Index: 17

A Bioinformatic Characterisation of the Glyolytic Enzyme ENO1 as a Biomarker of Breast Cancer Progression

2024/1/18

Athina Giannoudis
Athina Giannoudis

H-Index: 17

Vijay Sharma
Vijay Sharma

H-Index: 4

Abstract P5-14-10: Targetable alterations and genomic signatures within breast cancer brain metastases: Data from comprehensive genomic profiling of 761 breast cancer brain …

Cancer Research

2023/3/1

Athina Giannoudis
Athina Giannoudis

H-Index: 17

Identification of targetable genomic profiling of breast cancer brain metastases identifies alterations and genomic signatures relevant to immune-checkpoint and PARP inhibitors

2023/1/27

Athina Giannoudis
Athina Giannoudis

H-Index: 17

ENO1 as a biomarker of breast cancer progression and metastasis–a bioinformatic approach

medRxiv

2023

Vijay Sharma
Vijay Sharma

H-Index: 4

Athina Giannoudis
Athina Giannoudis

H-Index: 17

Characterisation of the immune microenvironment of primary breast cancer and brain metastasis reveals depleted T-cell response associated to ARG2 expression

Experimental Dermatology

2022/11

The role of CPT1A as a biomarker of breast cancer progression: a bioinformatic approach

Scientific Reports

2022/9/30

Athina Giannoudis
Athina Giannoudis

H-Index: 17

Vijay Sharma
Vijay Sharma

H-Index: 4

20P The importance of ARG2 expression in the immune-depleted microenvironment of primary breast cancer and brain metastasis

Annals of Oncology

2022/5/1

Abstract P5-07-04: Comprehensive analysis of the gene rearrangements within 822 breast cancer brain metastases reveals an enrichment of cyclin dependent kinase 12 …

Cancer Research

2022/2/15

Athina Giannoudis
Athina Giannoudis

H-Index: 17

Abstract PD4-09: Comprehensive assessment of the genomic landscape of breast cancer brain metastases reveals targetable alterations and genomic signatures relevant to immune …

Cancer Research

2022/2/15

Athina Giannoudis
Athina Giannoudis

H-Index: 17

1′-Acetoxychavicol Acetate from alpinia galanga represses proliferation and invasion, and induces apoptosis via HER2-signaling in endocrine-resistant breast cancer cells

Planta Medica

2022/2

Genomic profiling using the UltraSEEK panel identifies discordancy between paired primary and breast cancer brain metastases and an association with brain metastasis-free survival

Breast Cancer Research and Treatment

2021/11

Clinicopathologic and genomic landscape of breast carcinoma brain metastases

The Oncologist

2021/10/1

Athina Giannoudis
Athina Giannoudis

H-Index: 17

Lajos Pusztai
Lajos Pusztai

H-Index: 72

The genomic landscape of breast cancer brain metastases: a systematic review

2021/1/1

Athina Giannoudis
Athina Giannoudis

H-Index: 17

Abstract P4-09-07: UltraSEEK breast cancer panel for low frequency mutation detection in breast cancer brain metastasis

Cancer Research

2020/2/15

Abstract P4-05-22: A systematic review of the receptor status and genomic landscape of breast cancer brain metastases

2020/2/15

Athina Giannoudis
Athina Giannoudis

H-Index: 17

Abstract P6-04-18: The regulatory role of activating transcription factor-2 (ATF2) in modulating tamoxifen resistance in estrogen-receptor positive breast cancer

2020/2/15

Athina Giannoudis
Athina Giannoudis

H-Index: 17

The regulatory role of activating transcription factor-2 (ATF2) in modulating tamoxifen resistance in estrogen-receptor positive breast cancer

2020/2/1

Athina Giannoudis
Athina Giannoudis

H-Index: 17

Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer

Breast Cancer Research

2020/12

Athina Giannoudis
Athina Giannoudis

H-Index: 17

Triantafillos Liloglou
Triantafillos Liloglou

H-Index: 32

See List of Professors in Athina Giannoudis University(University of Liverpool)